AI assistant
Sending…
Dare Bioscience, Inc. — Director's Dealing 2015
Jul 6, 2015
34825_dirs_2015-07-06_e7e2624b-ffb1-4402-8381-bcd98adebccd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cerulean Pharma Inc. (CERU)
CIK: 0001401914
Period of Report: 2015-06-26
Reporting Person: TEPPER ROBERT I (Director)
More from Dare Bioscience, Inc.
Proxy Solicitation & Information Statement
2026
Jun 1
Proxy Solicitation & Information Statement
2026
Jun 1
Capital/Financing Update
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Annual Report
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Regulatory Filings
2026
Apr 22
Board/Management Information
2026
Apr 17
Capital/Financing Update
2026
Apr 13